Professional Experience
Michael Enzo Furrow, Ph.D. practices general intellectual property law with an emphasis on complex pharmaceutical and biotechnology patent litigation under the Hatch-Waxman Act. He has litigated patent infringement cases pertaining to drugs for treating Alzheimer's disease, breast cancer, epilepsy, gastroesophageal reflux disease, HIV/AIDS and various endocrine and vascular diseases. Dr. Furrow also has experience with inter partes and ex parte reexamination proceedings, pre-suit investigations, non-infringement opinions and intellectual property due diligence.
Dr. Furrow has published several articles in peer-reviewed journals in the field of synthetic organic chemistry; specifically in the areas of new bond-forming reactions and methods of asymmetric catalysis.
Awards and Recognition
Dr. Furrow was listed as a Rising Star in Intellectual Property in the 2011 issue of Super Lawyers: New York Metro Edition.
Professional Activities
American Intellectual Property Law Association; American Chemical Society; American Association for the Advancement of Science
Additional Publications
"Pharmaceutical Patent Life-Cycle Management after KSR v. Teleflex" Food and Drug Law Journal, 2008.
"A General Procedure for the Esterification of Carboxylic Acids with Diazo-alkanes Generated In Situ by the Oxidation of N-tert-Butyldimethylsilylhydrazones with (Difluoroiodo)benzene." Journal of the American Chemical Society, 2004.
"Practical Procedures for the Preparation of N-tert-Butyldimethylsilyl-hydrazones and Their Use in Modified Wolff-Kishner Reductions and in the Synthesis of Vinyl Halides and gem-Dihalides." Journal of the American Chemical Society, 2004.
"Highly Selective Hydrolytic Kinetic Resolution of Terminal Epoxides Catalyzed by Chiral (salen)CoIII Complexes. Practical Synthesis of Enantioenriched Terminal Epoxides and 1,2-Diols." Journal of the American Chemical Society, 2002.
"Practical Access to Highly Enantioenriched C-3 Building Blocks via Hydrolytic Kinetic Resolution." Journal of Organic Chemistry, 1998.
"Practical Synthesis of Enantiomerically Enriched Glycidol by Kinetic Resolution of (±)-Epichlorohydrin and Dynamic Kinetic Resolution of (±)-Epibromohydrin." The Nucleus, 1998.
Representative Cases
Amgen et al. v. Teva Pharmaceuticals, et al.
D. Del. 2011
Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership v. Apotex, Inc. & Apotex, Corp.
S.D.N.Y. 2010